(Q24612655)
Statements
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) (English)
0 references
14 June 2013
0 references
288
0 references
24
0 references
17579-88
0 references
1 reference
1 reference
1 reference
1 reference
1 reference